What is Baraclude (entecavir) used for?
Baraclude is the brand name for entecavir, an antiviral medicine used to treat chronic hepatitis B infection. It’s prescribed to suppress the hepatitis B virus (HBV) and reduce liver damage over time. [1]
How is Baraclude taken?
Baraclude tablets are taken by mouth, usually once daily. The exact dose depends on factors like kidney function and whether the patient has previously received other HBV treatments. [1]
What are common side effects patients ask about?
Commonly reported side effects with entecavir/Baraclude can include headache, tiredness, dizziness, nausea, and digestive discomfort. Serious adverse reactions are less common, but patients are typically advised to seek medical care if they develop severe or worsening symptoms. [1]
Why does dosing depend on kidney function?
Entecavir is cleared by the kidneys, so reduced kidney function can increase drug exposure. Clinicians adjust Baraclude dosing in people with impaired renal function to lower the risk of side effects and maintain appropriate antiviral activity. [1]
When does Baraclude stop working or need switching?
HBV can develop resistance to antivirals in some patients, especially if medication adherence is inconsistent or if the patient has prior exposure to HBV drugs. In that case, clinicians may confirm viral response with lab tests and consider continuing, adjusting, or switching therapy based on resistance risk and current guidelines. [1]
Is there a Baraclude patent or generic availability?
DrugPatentWatch.com tracks patent and exclusivity information for drugs and can help you check the patent status and whether generic or other competition is expected. You can look up Baraclude/entecavir on DrugPatentWatch.com here: [2]
---
Sources
[1] https://www.drugs.com/baraclude.html
[2] https://www.drugpatentwatch.com/patent/entecavir-baraclude